Bio-Rad Laboratories (BIO) News Today → Don’t make this retirement mistake (From Sasco Gold LLC) (Ad) Free BIO Stock Alerts $281.40 -3.05 (-1.07%) (As of 03:55 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 11 at 2:58 PM | marketbeat.comCaxton Associates LP Has $3.45 Million Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)Caxton Associates LP boosted its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 472.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,677 shares of the medical researchJune 10 at 6:42 PM | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Acquired by Bellevue Group AGBellevue Group AG increased its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 5.1% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 141,147 shares of the medical research company's stock after acquiring an additiJune 9 at 5:13 AM | marketbeat.comThe Manufacturers Life Insurance Company Purchases 55,369 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)The Manufacturers Life Insurance Company raised its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 303.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 73,610 shares of tJune 8 at 7:50 PM | marketbeat.comQuadrature Capital Ltd Boosts Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)Quadrature Capital Ltd increased its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 87.8% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 23,820 shares of the medical research company's stockJune 6, 2024 | marketbeat.comCIBC Private Wealth Group LLC Takes $13.98 Million Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)CIBC Private Wealth Group LLC bought a new stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 43,287 shares of the medical researchJune 5, 2024 | marketbeat.comEisler Capital UK Ltd. Purchases Shares of 3,132 Bio-Rad Laboratories, Inc. (NYSE:BIO)Eisler Capital UK Ltd. acquired a new stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 3,132 shares of the medical research company's stJune 5, 2024 | americanbankingnews.comBio-Rad Laboratories (NYSE:BIO) Given Hold Rating at Jefferies Financial GroupJune 3, 2024 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Short Interest UpdateBio-Rad Laboratories, Inc. (NYSE:BIO - Get Free Report) saw a significant drop in short interest in May. As of May 15th, there was short interest totalling 653,400 shares, a drop of 10.9% from the April 30th total of 733,100 shares. Based on an average daily volume of 202,100 shares, the days-to-cover ratio is presently 3.2 days. Approximately 3.3% of the company's shares are short sold.June 3, 2024 | marketbeat.comCampbell & CO Investment Adviser LLC Buys Shares of 8,080 Bio-Rad Laboratories, Inc. (NYSE:BIO)Campbell & CO Investment Adviser LLC purchased a new position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 8,080 shares of the medical research company's sJune 3, 2024 | marketbeat.comJefferies Financial Group Reaffirms "Hold" Rating for Bio-Rad Laboratories (NYSE:BIO)Jefferies Financial Group reaffirmed a "hold" rating and set a $315.00 price target (down previously from $440.00) on shares of Bio-Rad Laboratories in a research note on Monday.June 2, 2024 | marketbeat.comUBS Group AG Sells 4,431 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)UBS Group AG decreased its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 11.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 35,496 shares of the medical research company's stock afteJune 2, 2024 | americanbankingnews.comBrokers Issue Forecasts for Bio-Rad Laboratories, Inc.'s Q2 2025 Earnings (NYSE:BIO)June 1, 2024 | marketbeat.comFranklin Resources Inc. Cuts Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)Franklin Resources Inc. cut its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 27.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 19,000 shares of the medical research company's stock after selling 7,3May 31, 2024 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Purchased by Parnassus Investments LLCParnassus Investments LLC boosted its position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 7.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 237,790 shares of the medical research company's stock after aMay 31, 2024 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Expected to Post Q2 2025 Earnings of $2.64 Per ShareBio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) - Equities research analysts at Zacks Research boosted their Q2 2025 EPS estimates for Bio-Rad Laboratories in a note issued to investors on Tuesday, May 28th. Zacks Research analyst R. Anand now expects that the medical research company will poMay 30, 2024 | businesswire.comBio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics GroupMay 29, 2024 | marketbeat.comFirst Pacific Advisors LP Acquires New Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)First Pacific Advisors LP acquired a new stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 4,866 shares of the medical research company's stock, valued at approximatelyMay 28, 2024 | marketbeat.comBio-Rad Laboratories Q1 Earnings TranscriptMay 28, 2024 | marketbeat.comBio-Rad Laboratories (NYSE:BIO) Upgraded to "Buy" at StockNews.comStockNews.com upgraded Bio-Rad Laboratories from a "hold" rating to a "buy" rating in a research report on Tuesday.May 27, 2024 | marketbeat.com226,523 Shares in Bio-Rad Laboratories, Inc. (NYSE:BIO) Acquired by Norges BankNorges Bank purchased a new position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 226,523 shares of the medical research company's stock, vaMay 26, 2024 | marketbeat.comWestfield Capital Management Co. LP Sells 115,118 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Westfield Capital Management Co. LP lowered its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 31.8% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 247,210 shares of the medical research companyMay 23, 2024 | businesswire.comBio-Rad's Management to Participate in Fireside Chat During Jefferies Global Healthcare ConferenceMay 23, 2024 | marketbeat.comBrown Advisory Inc. Cuts Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)Brown Advisory Inc. lessened its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 98.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 15,569 shares of the medical researchMay 23, 2024 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Receives Average Rating of "Moderate Buy" from BrokeragesBio-Rad Laboratories, Inc. (NYSE:BIO - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the five research firms that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a hold recommendation and four have assigned a buy recomMay 22, 2024 | marketbeat.comING Groep NV Boosts Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)ING Groep NV increased its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 5,200.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 6,466 shares of the medical research company's stock after purchasing an additional 6,344 sharesMay 21, 2024 | marketbeat.comGW&K Investment Management LLC Sells 6,921 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)GW&K Investment Management LLC reduced its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 4.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 137,793 shares of the medical research company's stoMay 20, 2024 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Envestnet Portfolio Solutions Inc.Envestnet Portfolio Solutions Inc. cut its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 50.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,551 shares of the medical research company's stocMay 18, 2024 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Acquired by BNP Paribas Financial MarketsBNP Paribas Financial Markets boosted its position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 88.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 26,925 shares of the medical research cMay 15, 2024 | marketbeat.comJump Financial LLC Purchases Shares of 5,163 Bio-Rad Laboratories, Inc. (NYSE:BIO)Jump Financial LLC purchased a new position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 5,163 shares of the medical reseMay 14, 2024 | markets.businessinsider.comPrecision BioSciences earnings: here's what Wall Street expectsMay 12, 2024 | marketbeat.comRoubaix Capital LLC Makes New $4.05 Million Investment in Bio-Rad Laboratories, Inc. (NYSE:BIO)Roubaix Capital LLC purchased a new position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 12,549 shares of the medical research comMay 11, 2024 | marketbeat.comMawer Investment Management Ltd. Cuts Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)Mawer Investment Management Ltd. reduced its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 23.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 123,878 shares of the medical researcMay 10, 2024 | marketbeat.comNatixis Advisors L.P. Boosts Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)Natixis Advisors L.P. raised its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 17.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 20,744 shares of theMay 9, 2024 | marketbeat.comSwiss National Bank Sells 3,400 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Swiss National Bank lowered its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 4.8% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 67,600 shares of the medical research company's stock after selling 3,400 shares during the periMay 8, 2024 | marketbeat.comBio-Rad Laboratories (NYSE:BIO) Releases Quarterly Earnings Results, Beats Expectations By $0.25 EPSBio-Rad Laboratories (NYSE:BIO - Get Free Report) released its earnings results on Tuesday. The medical research company reported $2.29 EPS for the quarter, beating the consensus estimate of $2.04 by $0.25. The firm had revenue of $610.82 million during the quarter, compared to analysts' expectations of $619.09 million. Bio-Rad Laboratories had a negative net margin of 23.86% and a positive return on equity of 3.90%. The business's quarterly revenue was down 9.8% compared to the same quarter last year. During the same period in the prior year, the company earned $3.34 EPS.May 8, 2024 | marketbeat.comBio-Rad Laboratories (NYSE:BIO) Price Target Cut to $385.00 by Analysts at UBS GroupUBS Group decreased their price objective on Bio-Rad Laboratories from $420.00 to $385.00 and set a "buy" rating for the company in a report on Wednesday.May 8, 2024 | finance.yahoo.comQ1 2024 Bio Rad Laboratories Inc Earnings CallMay 7, 2024 | markets.businessinsider.comBIO Stock Earnings: Bio-Rad Laboratories Beats EPS, Misses Revenue for Q1 2024May 7, 2024 | reuters.comBio-Rad Laboratories reiterates 2024 revenue growth outlook; shares slipMay 7, 2024 | businesswire.comBio-Rad Reports First-Quarter 2024 Financial ResultsMay 7, 2024 | marketbeat.comTruist Financial Corp Cuts Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)Truist Financial Corp trimmed its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 21.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 11,635 shares of the medical research company's stock aftMay 5, 2024 | marketbeat.comFisher Asset Management LLC Sells 14,338 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Fisher Asset Management LLC lowered its position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 15.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 80,570 shares of the medical research company's stock after selling 14,33May 1, 2024 | finance.yahoo.comBio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare ConferenceMay 1, 2024 | businesswire.comBio-Rad's Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare ConferenceApril 30, 2024 | marketbeat.comBio-Rad Laboratories (BIO) Scheduled to Post Earnings on TuesdayBio-Rad Laboratories (NYSE:BIO) will be releasing earnings after the market closes on Tuesday, May 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=586339)April 29, 2024 | marketbeat.comAnchor Capital Advisors LLC Sells 20,844 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Anchor Capital Advisors LLC lowered its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 21.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 76,698 shares of the mApril 28, 2024 | marketbeat.comIFM Investors Pty Ltd Makes New Investment in Bio-Rad Laboratories, Inc. (NYSE:BIO)IFM Investors Pty Ltd bought a new stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 4,057 shares of the medical research company's stock, valued at approxApril 27, 2024 | marketbeat.comSector Gamma AS Makes New $7.62 Million Investment in Bio-Rad Laboratories, Inc. (NYSE:BIO)Sector Gamma AS bought a new position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 23,609 shares of the medical research company's stock, valued at approximatelyApril 26, 2024 | businesswire.comBio-Rad Announces Life Science Group Management ChangesApril 23, 2024 | usatoday.comS&P 500 (SPX) today: Top movers are Bio-Rad Laboratories Inc and Agilent Technologies, Inc. Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter. Email Address "If I Die, I’d Trust 50% of My Daughters’ Inheritance in ONE Stock." (Ad)"I'd Feel Secure Putting 50% of My Kids' Inheritance in THIS Stock" One Wall Street millionaire bought AAPL at $0.35 and AMZN under $2.50. Now, he says ONE stock could be the single smartest way to pass wealth to your family. It's outperformed traditional inheritance vehicles like annuities, life insurance, real estate, and gold by as much as 13 times, with tax advantages not many other investments offer. He reveals the name and ticker for free, right here. BIO Media Mentions By Week BIO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIO News Sentiment▼1.290.74▲Average Medical News Sentiment BIO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIO Articles This Week▼75▲BIO Articles Average Week Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Mettler-Toledo International News Illumina News Waters News Bio-Techne News Charles River Laboratories International News Bruker News Pacific Biosciences of California News aTyr Pharma News Harvard Bioscience News Thermo Fisher Scientific News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BIO) was last updated on 6/11/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredExecutive Order To Wipe Out Your Bank AccountsDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredNVDA to close the AI “wealth window’ June 25?On Tuesday, June 25, in front of executives from nearly every major tech company in existence, key leaders at ...Paradigm Direct | SponsoredThe Greatest LEGAL Transfer of Wealth in History is UnderwayWhat's the #1 Stock to Build Generational Wealth RIGHT NOW? One Wall Street millionaire will give you a sur...Stansberry Research | SponsoredDON’T buy gold until you read thisIf you're an American who understands that your money is rotting away as you read this email… Then this is ...Sasco Gold LLC | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | Sponsored